THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

UBS ASSET MANAGEMENT AMERICAS INC's Holding History (CIK: 0000861177)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 399 Value ($000) $7 Avg Close $16.59 Range $13.50 - $20.33
Q4 2024
Shares 150,039 Value ($000) $1,412 Avg Close $9.10 Range $7.88 - $10.26
Q3 2024
Shares 117,505 Value ($000) $947 Avg Close $8.66 Range $7.44 - $10.42
Q2 2024
Shares 138,877 Value ($000) $1,178 Avg Close $9.03 Range $8.13 - $10.44
Q1 2024
Shares 64,528 Value ($000) $579 Avg Close $9.27 Range $8.21 - $11.71
Q4 2023
Shares 64,528 Value ($000) $725 Avg Close $10.06 Range $8.52 - $11.57
Q3 2023
Shares 61,415 Value ($000) $530 Avg Close $9.65 Range $8.25 - $10.59
Q2 2023
Shares 61,415 Value ($000) $666 Avg Close $11.04 Range $9.98 - $12.03
Q1 2023
Shares 61,415 Value ($000) $666 Avg Close $10.57 Range $9.25 - $11.52
Q4 2022
Shares 65,039 Value ($000) $730 Avg Close $10.51 Range $9.56 - $11.83
Q3 2022
Shares 72,418 Value ($000) $734,320 Avg Close $9.37 Range $7.53 - $11.00
Q2 2022
Shares 72,418 Value ($000) $656,108 Avg Close $9.21 Range $8.15 - $10.52
Q1 2022
Shares 74,763 Value ($000) $714,735 Avg Close $9.80 Range $7.71 - $13.17
Q4 2021
Shares 74,154 Value ($000) $819,401 Avg Close $8.72 Range $7.30 - $11.24
Q3 2021
Shares 64,500 Value ($000) $477,301 Avg Close $11.19 Range $6.10 - $15.01
Q2 2021
Shares 63,921 Value ($000) $928,133 Avg Close $18.78 Range $14.46 - $22.74
Q1 2021
Shares 60,794 Value ($000) $1,240,806 Avg Close $19.01 Range $16.46 - $21.21
Q4 2020
Shares 60,794 Value ($000) $1,080,310 Avg Close $17.95 Range $14.48 - $20.53
Q3 2020
Shares 43,428 Value ($000) $642,083 Avg Close $18.73 Range $14.62 - $22.82
Q2 2020
Shares 43,428 Value ($000) $911,554 Avg Close $25.69 Range $20.17 - $31.35
Q1 2020
Shares 33,804 Value ($000) $781,211 Avg Close $25.03 Range $16.86 - $31.54
Q4 2019
Shares 33,757 Value ($000) $873,969 Avg Close $19.43 Range $15.72 - $26.47
Q3 2019
Shares 26,825 Value ($000) $522,551 Avg Close $20.20 Range $16.00 - $24.34
Q2 2019
Shares 13,129 Value ($000) $214,396 Avg Close $20.26 Range $15.18 - $25.38
Q1 2019
Shares 13,129 Value ($000) $297,635 Avg Close $25.36 Range $21.04 - $28.63
Q4 2018
Shares 20,377 Value ($000) $521,447 Avg Close $27.00 Range $21.70 - $35.48
Q3 2018
Shares 17,277 Value ($000) $564,440 Avg Close $27.25 Range $22.26 - $32.79
Q2 2018
Shares 9,119 Value ($000) $206,819 Avg Close $23.74 Range $21.27 - $26.00
Q1 2018
Shares 9,119 Value ($000) $221,136 Avg Close $27.46 Range $22.90 - $30.29
Q4 2017
Shares 17,077 Value ($000) $476,278 Avg Close $29.59 Range $25.20 - $35.90
Q3 2017
Shares 23,998 Value ($000) $821,692 Avg Close $32.70 Range $23.15 - $42.61
Q2 2017
Shares 20,826 Value ($000) $829,708 Avg Close $38.45 Range $34.85 - $43.44
Q1 2017
Shares 6,719 Value ($000) $247,394 Avg Close $31.95 Range $27.80 - $37.18
Q4 2016
Shares 6,719 Value ($000) $214 Avg Close $31.02 Range $24.54 - $38.92
Q3 2016
Shares 12,019 Value ($000) $436 Avg Close $27.84 Range $21.97 - $37.14
Q2 2016
Shares 12,019 Value ($000) $273 Avg Close $21.59 Range $15.00 - $24.76
Q1 2015
Shares 471,712 Value ($000) $8,184 Avg Close $18.33 Range $14.59 - $22.00
Q4 2014
Shares 233,812 Value ($000) $3,488 Avg Close $17.42 Range $13.11 - $24.06
Q3 2014
Shares 230,712 Value ($000) $5,318 Avg Close $29.01 Range $23.01 - $34.07
Q2 2014
Shares 220,912 Value ($000) $7,043 Avg Close $27.05 Range $14.75 - $35.67